EZR and cancer: The aberrant expression of ezrin is associated with the development and progression of several human cancers, such as hepatocellular carcinoma [5,6], lung cancer [7,8], breast carcinoma [9], pancreatic adenocarcinoma [10], colon cancer [11], osteosarcoma [12,13], rhabdomyosarcoma [14,15], and endometrial cancer [16].